How COPD patients with Gln27Glu polymorphism utilize exacerbation-related drugs?
K. Dmytriiev (21029, Ukraine), Y. Mostovoy (21029, Ukraine), N. Slepchenko (21029, Ukraine), Y. Smereka (21029, Ukraine), D. Dmytriiev (21029, Ukraine)
Source: International Congress 2022 – Biomarkers and lung function in COPD exacerbation
Session: Biomarkers and lung function in COPD exacerbation
Session type: Thematic Poster
Number: 4044
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Dmytriiev (21029, Ukraine), Y. Mostovoy (21029, Ukraine), N. Slepchenko (21029, Ukraine), Y. Smereka (21029, Ukraine), D. Dmytriiev (21029, Ukraine). How COPD patients with Gln27Glu polymorphism utilize exacerbation-related drugs?. 4044
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|